Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Novo Nordisk A/S
Patrick M O'Neil; Andreas L Birkenfeld; Barbara McGowan; Ofri Mosenzon; Sue D Pedersen; Sean Wharton; Charlotte Giwercman Carson; Cecilie Heerdegen Jepsen; Maria Kabisch; John P H Wilding